James G. Marken Ani Pharmaceuticals Inc (ANIP) insider trading activity

James G. Marken is SVP OPS & PROD DEV of ANI PHARMACEUTICALS INC. Currently has a direct ownership of 117,829 shares of ANIP, which is worth approximately $6.41 Million. The most recent transaction as insider was on Jun 07, 2024, when has been sold 11,087 shares (Common Stock) at a price of $67.7 per share, resulting in proceeds of $750,589. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 118K

0% 3M change

11.48% 12M change

Total Value Held $6.41 Million

James G. Marken Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 07 2024	SELL Payment of exercise price or tax liability	$750,589 $67.7 p/Share	11,087 Reduced 8.6%	117,829 Common Stock
Jun 07 2024	BUY Exercise of conversion of derivative security	$668,789 $53.29 p/Share	12,550 Added 8.87%	128,916 Common Stock
Apr 10 2024	SELL Payment of exercise price or tax liability	$187,421 $66.96 p/Share	2,799 Reduced 2.36%	116,006 Common Stock
Mar 23 2024	SELL Payment of exercise price or tax liability	$254,175 $69.58 p/Share	3,653 Reduced 2.98%	118,805 Common Stock
Mar 07 2024	SELL Payment of exercise price or tax liability	$135,688 $66.71 p/Share	2,034 Reduced 1.63%	122,458 Common Stock
Mar 07 2024	SELL Open market or private sale	$1,615,313 $66.37 p/Share	24,338 Reduced 16.35%	124,492 Common Stock
Feb 29 2024	SELL Payment of exercise price or tax liability	$71,594 $67.67 p/Share	1,058 Reduced 0.71%	148,830 Common Stock
Feb 14 2024	BUY Grant, award, or other acquisition	-	16,776 Added 10.07%	149,888 Common Stock
Aug 23 2023	SELL Open market or private sale	$247,716 $63.0 p/Share	3,932 Reduced 2.87%	133,112 Common Stock
Aug 23 2023	BUY Exercise of conversion of derivative security	$199,345 $36.8 p/Share	5,417 Added 3.8%	137,044 Common Stock
Apr 10 2023	SELL Payment of exercise price or tax liability	$88,126 $38.5 p/Share	2,289 Reduced 1.71%	131,627 Common Stock
Mar 28 2023	SELL Payment of exercise price or tax liability	$20,236 $38.62 p/Share	524 Reduced 0.46%	112,206 Common Stock
Mar 23 2023	SELL Payment of exercise price or tax liability	$92,734 $37.82 p/Share	2,452 Reduced 2.13%	112,730 Common Stock
Mar 07 2023	SELL Payment of exercise price or tax liability	$108,805 $44.23 p/Share	2,460 Reduced 2.09%	115,182 Common Stock
Feb 28 2023	BUY Grant, award, or other acquisition	-	21,710 Added 13.95%	133,916 Common Stock
Aug 15 2022	SELL Open market or private sale	$195,450 $37.79 p/Share	5,172 Reduced 4.21%	117,642 Common Stock
Aug 12 2022	SELL Open market or private sale	$477,594 $37.04 p/Share	12,894 Reduced 9.5%	122,814 Common Stock
Apr 27 2022	BUY Grant, award, or other acquisition	-	6,644 Added 4.67%	135,708 Common Stock
Apr 10 2022	SELL Payment of exercise price or tax liability	$56,171 $29.91 p/Share	1,878 Reduced 1.43%	129,064 Common Stock
Apr 06 2022	SELL Payment of exercise price or tax liability	$10,006 $29.69 p/Share	337 Reduced 0.26%	130,942 Common Stock
Mar 28 2022	SELL Payment of exercise price or tax liability	$14,761 $28.17 p/Share	524 Reduced 0.4%	131,279 Common Stock
Mar 24 2022	BUY Grant, award, or other acquisition	-	19,934 Added 13.14%	131,803 Common Stock
Mar 23 2022	SELL Payment of exercise price or tax liability	$66,278 $27.03 p/Share	2,452 Reduced 2.14%	111,869 Common Stock
Apr 12 2021	SELL Payment of exercise price or tax liability	$59,833 $31.86 p/Share	1,878 Reduced 1.62%	114,321 Common Stock
Apr 06 2021	SELL Payment of exercise price or tax liability	$11,354 $33.69 p/Share	337 Reduced 0.29%	116,199 Common Stock

JGM

James G. Marken

SVP OPS & PROD DEV

Baudette, MN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANIP shares.

Notify only if

Value

Insider Trading

Get notified when an Ani Pharmaceuticals Inc insider buys or sells ANIP shares.

Notify only if

Operation

Value

Type

News

Receive news related to ANI PHARMACEUTICALS INC

Track Activities on ANIP

Account